Mary Wozniak, Senior Research Associate

Mary seeks to uncover the mechanism of action behind progranulin haploinsufficiency to gain a more holistic understanding of FTD-GRN. She’s driven by the large unmet need to develop therapies for neurodegenerative diseases and the potential to dramatically improve the quality of life for those affected.

She obtained her BS in behavioral neuroscience from Northeastern University and has over three years of industry experience in developing drugs to treat neurodegenerative disease.